Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,221.48, giving the company a market capitalization of 1.24T. It carries a P/E multiple of 41.29 and pays a dividend yield of 0.53%.
On 2026-08-12, Eli Lilly(LLY) stock traded between a low of $1,191.08 and a high of $1,226.50. Shares are currently priced at $1,221.48, which is +2.6% above the low and -0.4% below the high.
The Eli Lilly(LLY)'s current trading volume is 1.94M, compared to an average daily volume of 3.3M.
During the past year, Eli Lilly(LLY) stock moved between $629.40 at its lowest and $1,249.45 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $629.40 at its lowest and $1,249.45 at its peak.
LLY News
(RTTNews) - Eli Lilly (LLY) on Wednesday filed six lawsuits against U.S. companies it accused of illegally selling unauthorized versions of its experimental obe...
...
Eli Lilly and Company has committed to roll out Veeva Vault CRM across its global operations, adopting Veeva’s agentic, AI-enabled commercial platform as its co...
Analyst ratings
81%
of 31 ratingsMore LLY News
These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Arista Beats Views 8/08/2026 Among the best stocks in earnings performance, highly rated...
Pharmaceutical giant Eli Lilly (LLY) has filed lawsuits against six U.S. companies that it accuses of illegally selling black-market versions of its experiment...
Eli Lilly has sued six companies, saying they are illegally selling versions of the unapproved weight-loss drug retatrutide. Eli Lilly is suing six pharmacies...
Eli Lilly & Co. (LLY), the manufacturer of weight-loss drugs Mounjaro and Zepbound, has filed six lawsuits against U.S. businesses for illegally selling version...
Eli Lilly & Co. is stepping up its fight against a booming black market for retatrutide, an experimental drug that the company is counting on to expand its cruc...
Amazon Pharmacy launches a program to offer Eli Lilly (NYSE: LLY) weight-loss drug Zepbound to eligible Medicare patients for US$50 per month using a new federa...
Key Points Eli Lilly has a stronger GLP-1 portfolio and pipeline than Novo Nordisk. Eli Lilly also has a better lineup outside the diabetes and weight-loss ar...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.